Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The Brazil vaccine market was valued at USD 4.16 Billion in 2025, driven by the surge in infectious disease cases and rising public-private partnerships in the region. The market is anticipated to grow at a CAGR of 6.10% during the forecast period of 2026-2035, with the values likely to reach USD 7.52 Billion by 2035. The market is propelled by the growing public health infrastructure and high vaccination acceptance rates. Expanding adult vaccination programs and advancements in mRNA vaccine technologies are expected to fuel demand in the forecast period.
Q1 2026 Market Updates
The Iran-US-Israel conflict that escalated on February 28, 2026, presents growing supply chain risks for the Brazil vaccine market, valued at approximately USD 3.92 billion in 2025 and projected to grow at a 6.1% CAGR through 2034. The near-total closure of the Strait of Hormuz has reduced commercial shipping by 90%, while Gulf region air-cargo capacity dropped 79% in the first week. Cold-chain vaccines - requiring strict temperature control with short shelf lives - are among the most vulnerable products to these logistics disruptions. Analysts estimate carriers could need a week and a half to recover for every week air shipments are suspended.
Brazil's vaccine ecosystem benefits from domestic manufacturing through Bio-Manguinhos/Fiocruz and the Butantan Institute, which supply the National Immunization Program. In February 2025, Brazil announced plans to launch a domestically produced single-dose dengue vaccine by 2026 targeting 60 million annual doses. However, Brazil still relies on imported active pharmaceutical ingredients containing petroleum-derived substances that now cost more due to the conflict. The disruption of Gulf air hubs - connecting pharmaceutical suppliers in Asia, Europe, and India with Latin American markets - adds delivery uncertainty for imported vaccine components.
Brazil's vaccine contract manufacturing sector, valued at USD 0.52 billion in 2024, faces elevated input costs as pharmaceutical raw material prices have risen 5-100% since the conflict began. Maritime insurance premiums for Strait of Hormuz transit have surged over 1,000%, cascading through the supply chain. Brazil's partnership with PAHO's Revolving Funds for vaccine procurement provides some buffer through bulk purchasing, but prolonged disruptions could strain these mechanisms.
While short-term shortages remain unlikely due to inventory buffers, the conflict underscores the importance of Brazil's investments in vaccine self-sufficiency. Strengthening domestic production and regional supply partnerships across Latin America will be essential to insulating immunization programs from geopolitical volatility.
Key Takeaways
Government: Brazilian health authorities should accelerate domestic vaccine production, particularly the planned dengue vaccine, while expanding Fiocruz and Butantan capacity to reduce dependence on imported ingredients affected by the Strait of Hormuz closure. The PAHO Revolving Funds partnership should be leveraged for advance ordering of critical vaccine supplies.
Market: The Brazil vaccine market faces rising input costs as petroleum-derived pharmaceutical ingredients and cold-chain logistics expenses climb due to the Middle East conflict. Contract manufacturers must manage margin pressures from raw material price increases while maintaining output targets for the National Immunization Program.
Procurement: Procurement teams should diversify ingredient sourcing beyond Gulf-dependent routes and build advance inventory of critical vaccine components. Strengthening regional supply partnerships within Latin America and securing forward contracts with domestic manufacturers can reduce exposure to the volatile international logistics environment.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In April 2025, Brazil's Ministry of Health advanced plans to incorporate the chikungunya vaccine into the public health system. This initiative is expected to enhance disease prevention, expand immunization coverage, and significantly boost the Brazil vaccine market.
-
One of the key trends in the market is the push toward national vaccine self-sufficiency. In February 2025, Brazil announced plans to launch a 100% domestically produced, single-dose dengue vaccine by 2026, with an annual target of 60 million doses.
-
In February 2024, Takeda prioritized Brazilian public health by committing 6.6 million dengue vaccine doses for 2024 and 9 million for 2025, supporting the national immunization campaign. Such proactive initiatives by the leading market players are poised to elevate the market value.
Compound Annual Growth Rate
6.1%
Value in USD Billion
2026-2035
*this image is indicative*
Brazil Vaccine Market Overview
A vaccine is a biological substance designed to stimulate the body’s immune response against one or more specific diseases. It trains the immune system to recognize and combat pathogens, such as viruses or bacteria, by introducing harmless components or inactivated forms of the pathogen. This helps prevent future infections and supports public health through immunization. The market is expanding due to rising government immunization programs, increased awareness, and growing demand for COVID-19 and influenza vaccines, supported by both domestic production and international pharmaceutical collaborations.
Brazil Vaccine Market Growth Drivers
Surge in Dengue Cases to Drive Market Demand
The sharp rise in dengue fever cases is emerging as a significant growth driver for the market. According to data from the Brazilian Health Ministry, in February 2024, Brazil reported 262,247 dengue cases in the first four weeks, which is four times the number of cases recorded during the same period in 2023, creating an urgent demand for vaccination. This public health crisis, coupled with increasing vaccination demand, is set to substantially accelerate growth in the vaccine market in Brazil.
Brazil Vaccine Market Trends
Some of the notable trends in the market are the large-scale dengue vaccination initiative and robust collaboration between the federal government and the private sector:
Brazil Vaccine Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Multivalent Vaccines
- Monovalent Vaccines
Market Breakup by Type
- Subunit Vaccines
- Recombinant vaccines
- Conjugate Vaccines
- Toxoid vaccines
- Inactivated
- Live Attenuated
- mRNA vaccines
- Viral vector vaccines
Market Breakup by Route of Administration
- Oral
- Parenteral
- Nasal
Market Breakup by Disease Indication
- Viral Diseases
- Hepatitis
- Influenza
- HPV
- MMR
- Rotavirus
- Herpes Zoster
- Covid-19
- Others
- Bacterial Vaccines
- Meningococcal Diseases
- Pneumococcal diseases
- DPT
- Others
- Cancer Vaccines
- Allergy Vaccines
Market Breakup by Age
- Pediatric
- Adult
Market Breakup by End User
- Hospital Pharmacies
- Retail Pharmacies
- Government Suppliers
- Others
Brazil Vaccine Market Share
The Viral Disease Segment Holds a Substantial Market Share
Based on the disease indication, the market is divided into viral diseases, bacterial vaccines, cancer vaccines, and allergy vaccines. Among these, viral diseases are expected to lead the vaccine market due to the ongoing global focus on infectious diseases such as influenza, COVID-19, and dengue. The growing demand for vaccines targeting these viruses, combined with advancements in vaccine technology, is anticipated to elevate the market value.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Brazil Vaccine Market Analysis by Region
The southeast region, including states like São Paulo and Minas Gerais, leads the Brazil vaccine market due to its high population density and advanced healthcare infrastructure. The south and central-west regions also show strong growth, driven by improved immunization programs and rising healthcare investments. These regions collectively account for the majority of vaccine demand and distribution.
Leading Players in the Brazil Vaccine Market
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GlaxoSmithKline plc
GSK plc, founded in 2000 and headquartered in Brentford, UK, is a global leader in healthcare and vaccines. The company plays a significant role in the Brazil vaccine market with its RSV vaccine, Arexvy, which is available in over 60 countries. At the International RSV Symposium in March 2024, GSK presented pivotal research on Arexvy, emphasizing its immunogenicity, safety, and efficacy, especially for older adults and immunocompromised individuals, addressing the growing demand for RSV vaccines in Brazil.
Merck & Co
Merck & Co., Inc., established in 1891, is a global leader in healthcare. The company, also known as MSD outside the United States and Canada, develops and manufactures vaccines for various diseases, including dengue, influenza, and COVID-19. Merck’s global vaccination efforts, such as collaborations with Gavi, enhance vaccine access and confidence, supporting Brazil's vaccination initiatives in response to rising dengue cases.
Pfizer Inc
Pfizer is a key player in the market, producing a wide range of vaccines and medicines. It was established in 1849 and is headquartered in New York. In collaboration with Gavi, Pfizer has made significant contributions to vaccination efforts, including its pneumococcal conjugate vaccines. These vaccines, crucial for preventing pneumonia in children, support immunization initiatives, especially in vulnerable populations, and align with the country's broader health equity goals.
AstraZeneca plc
AstraZeneca plc, established in 1999, is headquartered in Cambridge, United Kingdom. In the Brazil vaccine market, AstraZeneca plays a crucial role with its COVID-19 vaccine, developed in partnership with the University of Oxford. Approved for emergency use in January 2021, the AstraZeneca vaccine has been integral to Brazil's national vaccination efforts during the pandemic.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sanofi, Johnson & Johnson Services, Inc., and CSL Behring.
Key Questions Answered in the Brazil Vaccine Market Report
- What was the Brazil vaccine market value in 2025?
- What is the Brazil vaccine market forecast outlook for 2026-2035?
- What is the market segmentation based on product type?
- What is the market segmentation based on type?
- What is the market breakup based on the route of administration?
- How is the market segmented based on disease indication?
- How is the market divided based on age?
- How is the market divided based on the end user?
- What are the major factors aiding the Brazil vaccine market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Brazil Vaccine market trends?
- Which product type is expected to dominate the market segment?
- Which type is projected to lead the market segment?
- Which route of administration is projected to lead the market segment?
- Which disease indication is projected to lead the market segment?
- Which age is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the Brazil vaccine market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
More Insights On
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Disease Indication |
|
| Breakup by Age |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share